RU2009139485A - PHARMACEUTICAL COMPOSITION CONSISTING OF CANDEXARTAN CILEXETIL AND METHOD FOR PRODUCING IT - Google Patents
PHARMACEUTICAL COMPOSITION CONSISTING OF CANDEXARTAN CILEXETIL AND METHOD FOR PRODUCING IT Download PDFInfo
- Publication number
- RU2009139485A RU2009139485A RU2009139485/15A RU2009139485A RU2009139485A RU 2009139485 A RU2009139485 A RU 2009139485A RU 2009139485/15 A RU2009139485/15 A RU 2009139485/15A RU 2009139485 A RU2009139485 A RU 2009139485A RU 2009139485 A RU2009139485 A RU 2009139485A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- polyethylene glycol
- polyvinyl alcohol
- composition according
- candesartan cilexetil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Стабильная фармацевтическая композиция в виде твердого вещества для перорального применения, содержащая в качестве действующего вещества кандесартан цилексетил, отличающаяся тем, что в качестве стабилизатора содержит привитой сополимер поливинилового спирта и полиэтиленгликоля. ! 2. Фармацевтическая композиция по п.1, отличающаяся тем, что температура плавления привитого сополимера поливинилового спирта и полиэтиленгликоля выше 150°С, благоприятно выше 200°С. ! 3. Фармацевтическая композиция по п.1, отличающаяся тем, что дополнительно содержит одно или более фармацевтически допустимых вспомогательных веществ. ! 4. Фармацевтическая композиция по п.3, отличающаяся тем, что фармацевтически допустимые вспомогательные вещества выбраны из группы, включающей наполнители, связывающие вещества, разрыхлители, скользящие вещества и красители. ! 5. Способ получения стабильной фармацевтической композиции в виде твердого вещества для перорального применения, содержащей в качестве действующего вещества кандесартан цилексетил, отличающийся тем, что этот способ состоит из следующих этапов: ! а) смесь, состоящую из кандесартана цилексетила, наполнителя и связывающего вещества, подвергают влажной грануляции с использованием в качестве гранулирующего агента раствора привитого сополимера поливинилового спирта с полиэтиленгликолем и (не обязательно) красителя, ! б) полученный на этапе а) гранулят высушивают, ! в) к высушенному грануляту, полученному на этапе б), добавляют разрыхлитель и скользящее вещество, перемешивают и из полученной таким образом смеси изготавливают таблетки. ! 6. Способ получения фармацевтической к 1. A stable pharmaceutical composition in the form of a solid for oral administration, containing candesartan cilexetil as the active substance, characterized in that it contains a grafted copolymer of polyvinyl alcohol and polyethylene glycol as a stabilizer. ! 2. The pharmaceutical composition according to claim 1, characterized in that the melting point of the grafted copolymer of polyvinyl alcohol and polyethylene glycol is higher than 150 ° C, favorable above 200 ° C. ! 3. The pharmaceutical composition according to claim 1, characterized in that it further comprises one or more pharmaceutically acceptable excipients. ! 4. The pharmaceutical composition according to claim 3, characterized in that the pharmaceutically acceptable excipients are selected from the group comprising excipients, binders, disintegrants, glidants and colorants. ! 5. A method of obtaining a stable pharmaceutical composition in the form of a solid for oral administration containing candesartan cilexetil as the active substance, characterized in that this method consists of the following steps:! a) a mixture consisting of candesartan cilexetil, a filler and a binder is wet granulated using a graft copolymer of polyvinyl alcohol with polyethylene glycol and (optionally) a dye as a granulating agent,! b) obtained in stage a) the granulate is dried,! c) to the dried granulate obtained in step b), a disintegrant and a moving substance are added, mixed, and tablets are made from the mixture thus obtained. ! 6. The method of obtaining pharmaceutical to
Claims (6)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PLP.382080 | 2007-03-28 | ||
PL382080A PL207244B1 (en) | 2007-03-28 | 2007-03-28 | Oral pharmaceutical composition containing cylexetil candesartan and its production method |
PL384680A PL384680A1 (en) | 2007-03-28 | 2008-03-12 | Pharmaceutical composition containing cylexyethyl candesarthan and its production method |
PLP.384680 | 2008-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2009139485A true RU2009139485A (en) | 2011-05-10 |
Family
ID=39672763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2009139485/15A RU2009139485A (en) | 2007-03-28 | 2008-03-28 | PHARMACEUTICAL COMPOSITION CONSISTING OF CANDEXARTAN CILEXETIL AND METHOD FOR PRODUCING IT |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2139456A1 (en) |
PL (1) | PL384680A1 (en) |
RU (1) | RU2009139485A (en) |
WO (1) | WO2008118031A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101632678B (en) * | 2009-09-01 | 2011-09-14 | 严洁 | Losartan potassium hydrochlorothiazide composition and preparation method thereof |
JP2013075833A (en) * | 2011-09-29 | 2013-04-25 | Nihon Generic Co Ltd | Solid preparation containing candesartan cilexetil |
CN110638764A (en) * | 2019-09-23 | 2020-01-03 | 珠海润都制药股份有限公司 | Candesartan cilexetil quick-release pellet |
CN117442577B (en) * | 2023-12-21 | 2024-03-15 | 山东则正医药技术有限公司 | Candesartan cilexetil microchip and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003302881A1 (en) * | 2002-12-11 | 2004-06-30 | Ranbaxy Laboratories Limited | Coating composition for taste masking coating and methods for their application and use |
WO2005070398A2 (en) * | 2004-01-23 | 2005-08-04 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents |
WO2005079751A2 (en) * | 2004-01-23 | 2005-09-01 | Ranbaxy Laboratories Limited | Oral pharmaceutical compositions of candesartan cilexetil |
WO2005084648A1 (en) * | 2004-02-27 | 2005-09-15 | Ranbaxy Laboratories Limited | Pharmaceutical compositions comprising candesartan cilexetil |
-
2008
- 2008-03-12 PL PL384680A patent/PL384680A1/en not_active Application Discontinuation
- 2008-03-28 EP EP08741767A patent/EP2139456A1/en not_active Withdrawn
- 2008-03-28 RU RU2009139485/15A patent/RU2009139485A/en unknown
- 2008-03-28 WO PCT/PL2008/000026 patent/WO2008118031A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
PL384680A1 (en) | 2008-09-29 |
EP2139456A1 (en) | 2010-01-06 |
WO2008118031A1 (en) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2007145522A (en) | EXTRUSION METHOD FOR PREPARING COMPOSITIONS CONTAINING BAD PRESSURE MEDICINAL COMPOUNDS | |
US8686026B2 (en) | Solid compositions | |
RU2005111222A (en) | ORAL COMPOSITIONS | |
RU2007127995A (en) | SOLID, ORAL USE PHARMACEUTICAL APPLICATIONS CONTAINING RIVAROXABAN WITH MODIFIED RELEASE | |
RU2008106220A (en) | GASTRORETENTIVE COMPOSITIONS AND METHOD FOR THEIR MANUFACTURE | |
JP2007528388A5 (en) | ||
RU2009106681A (en) | GRANULAR PHARMACEUTICAL COMPOSITIONS | |
RU2009139485A (en) | PHARMACEUTICAL COMPOSITION CONSISTING OF CANDEXARTAN CILEXETIL AND METHOD FOR PRODUCING IT | |
RU2011127989A (en) | TABLETS BASED ON ACETATE ULIPRAL | |
WO2013191668A1 (en) | Compositions preventing hypertension comprising soluplus | |
MX2008002512A (en) | Drug compositions containing controlled release hypromellose matrices. | |
CA2797042A1 (en) | Fingolimod in the form of a solid solution | |
KR100522239B1 (en) | Compositions for controlled release acetaminophen dosage forms | |
AU2020239679A1 (en) | Crystal forms | |
WO2004100883A3 (en) | Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutual dosage forms and methods of preparing the same | |
JP5461565B2 (en) | Wet granulation of moxifloxacin using organic solvents | |
NO20083183L (en) | Solid pharmaceutical composition containing irbesartan | |
AU2020203494B2 (en) | Crystal forms | |
YU64001A (en) | Controlled-release compositions of betahistine | |
RU2009135981A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING IRBESARTAN | |
RU2007133793A (en) | COMPOSITIONS WITH CONTROLLED ALFUZOSINE RELEASE | |
RU2014145845A (en) | SLOW-DELIVER TABLET CONTAINING LEVODROPROPIZIN AND METHOD FOR ITS MANUFACTURE | |
RU2020109948A (en) | EXTRUDED ENZALUTAMIDE COMPOSITIONS | |
WO2015171162A1 (en) | Anti-viral compound | |
RU2010129544A (en) | PHARMACEUTICAL COMPOSITION |